162 related articles for article (PubMed ID: 34359739)
1. Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer.
Majumder M; Ugwuagbo KC; Maiti S; Lala PK; Brackstone M
Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359739
[TBL] [Abstract][Full Text] [Related]
2. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
[TBL] [Abstract][Full Text] [Related]
3. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
Feser R; Opperman RM; Nault B; Maiti S; Chen VC; Majumder M
Heliyon; 2023 Apr; 9(4):e15421. PubMed ID: 37128318
[TBL] [Abstract][Full Text] [Related]
5. Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer.
Hunter S; Nault B; Ugwuagbo KC; Maiti S; Majumder M
Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277414
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
7. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of blood-based miRNAs as diagnostic and prognostic nucleic acid markers in breast cancer: Comparative to conventional tumor markers.
Swellam M; Ramadan A; El-Hussieny EA; Bakr NM; Hassan NM; Sobeih ME; EzzElArab LR
J Cell Biochem; 2019 Aug; 120(8):12321-12330. PubMed ID: 30825229
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker.
Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E
BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191
[TBL] [Abstract][Full Text] [Related]
10. Investigation of relationship between precursor of miRNA-944 and its mature form in lung squamous-cell carcinoma - the diagnostic value.
Powrózek T; Mlak R; Dziedzic M; Małecka-Massalska T; Sagan D
Pathol Res Pract; 2018 Mar; 214(3):368-373. PubMed ID: 29496309
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the miR-17-92 cluster and miR-17 family in breast cancer according to tumor type; results from the Norwegian Women and Cancer (NOWAC) study.
Moi L; Braaten T; Al-Shibli K; Lund E; Busund LR
J Transl Med; 2019 Oct; 17(1):334. PubMed ID: 31581940
[TBL] [Abstract][Full Text] [Related]
12. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
13. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
14. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
[TBL] [Abstract][Full Text] [Related]
15. Potential diagnostic role of circulating MiRNAs in breast cancer: Implications on clinicopathological characters.
Swellam M; El Magdoub HM; Hassan NM; Hefny MM; Sobeih ME
Clin Biochem; 2018 Jun; 56():47-54. PubMed ID: 29679553
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-199a-3p: A potential circulating diagnostic biomarker for early gastric cancer.
Li C; Li JF; Cai Q; Qiu QQ; Yan M; Liu BY; Zhu ZG
J Surg Oncol; 2013 Aug; 108(2):89-92. PubMed ID: 23733518
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection.
Powrózek T; Kuźnar-Kamińska B; Dziedzic M; Mlak R; Batura-Gabryel H; Sagan D; Krawczyk P; Milanowski J; Małecka-Massalska T
Pathol Res Pract; 2017 Nov; 213(11):1384-1387. PubMed ID: 28964576
[TBL] [Abstract][Full Text] [Related]
19. Combined detection of plasma miR-127-3p and HE4 improves the diagnostic efficacy of breast cancer.
Lu M; Ju S; Shen X; Wang X; Jing R; Yang C; Chu H; Cong H
Cancer Biomark; 2017; 18(2):143-148. PubMed ID: 27983524
[TBL] [Abstract][Full Text] [Related]
20. Analysis of serum genome-wide microRNAs for breast cancer detection.
Wu Q; Wang C; Lu Z; Guo L; Ge Q
Clin Chim Acta; 2012 Jul; 413(13-14):1058-65. PubMed ID: 22387599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
